{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:52:36Z","timestamp":1773017556488,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003385","name":"Georg-August-Universit\u00e4t G\u00f6ttingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003385","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although Dementia with Lewy bodies (DLB) is the second most common form of dementia in elderly patients, it remains underdiagnosed compared with Alzheimer's (AD) and Parkinson's diseases (PD). This may be explained by overlapping clinical symptoms, e.g. Parkinsonism. While current MRI research focuses primarily on atrophy patterns of the frontal and temporal lobes, we focus on brainstem characteristics of DLB. In particular, we focused on brainstem atrophy patterns distinguishing DLB from Progressive Supranuclear Palsy (PSP) and PD based as the most common differential diagnoses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We identified patients diagnosed with DLB, PD, PSP, and a control group (CTRL) in our psychiatric and neurological archives. All patients with competing diagnoses and without a high-quality T1 MPRAGE 3D dataset were excluded. We assessed atrophy patterns in all patients (1) manually and (2) using FastSurfer\u2019s segmentation algorithm in combination with FreeSurfer\u2019s brainstem volumetric calculations. We compared classical measurement methods and ratios with automated volumetric approaches.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>One hundred two patients were enrolled and evaluated in this study. Patients with DLB (<jats:italic>n<\/jats:italic>\u2009=\u200937) showed on average less atrophy of the brainstem than patients with PSP (<jats:italic>n<\/jats:italic>\u2009=\u200921), but a significantly more pronounced atrophy than patients with PD (<jats:italic>n<\/jats:italic>\u2009=\u200936) and the control group (CTRL, <jats:italic>n<\/jats:italic>\u2009=\u20098). The mean measured sagittal diameters of the midbrain were 8.17\u2009\u00b1\u20091.06\u00a0mm (mean\u2009\u00b1\u2009standard deviation) for PSP, 9.45\u2009\u00b1\u20090.95\u00a0mm for DLB, 10.37\u2009\u00b1\u20090.99\u00a0mm for PD and 10.74\u2009\u00b1\u20090.70 for CTRL. The mean measured areas of the midbrain were 81\u2009\u00b1\u200918 mm<jats:sup>2<\/jats:sup> for PSP, 105\u2009\u00b1\u200917 mm<jats:sup>2<\/jats:sup> for DLB, 130\u2009\u00b1\u200926 mm<jats:sup>2<\/jats:sup> for PD and 135\u2009\u00b1\u200923 mm<jats:sup>2<\/jats:sup> for CTRL. The mean segmented volumes of the midbrain were 5595\u2009\u00b1\u2009680 mm<jats:sup>3<\/jats:sup> for PSP, 6051\u2009\u00b1\u2009566 mm<jats:sup>3<\/jats:sup> for DLB, 6646\u2009\u00b1\u2009802 mm<jats:sup>3<\/jats:sup> for PD and 6882\u2009\u00b1\u2009844 mm<jats:sup>3<\/jats:sup> for CTRL. The calculated midbrain pons ratios did not show superiority over the absolute measurements of the midbrain for distinguishing PSP from DLB. Because of the relatively uniform atrophy throughout the brainstem, the ratios were not suitable for distinguishing DLB from PD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>DLB patients exhibit homogenous atrophy of the brainstem and can be distinguished from patients with PSP and PD by both manual measurement methods and automated volume segmentation using absolute values or ratios.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-023-03151-4","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T12:03:06Z","timestamp":1679400186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson\u2019s disease on MRI"],"prefix":"10.1186","volume":"23","author":[{"given":"Sebastian Johannes","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eya","family":"Khadhraoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ala","family":"Jamous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian Heiner","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Bouter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"van Riesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Maass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bartl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marielle","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,21]]},"reference":[{"key":"3151_CR1","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","volume":"386","author":"Z Walker","year":"2015","unstructured":"Walker Z, Possin KL, Boeve BF, Aarsland D. Lewy body dementias. The Lancet. 2015;386:1683\u201397.","journal-title":"The Lancet"},{"key":"3151_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1017\/S0033291713000494","volume":"44","author":"SA Vann Jones","year":"2014","unstructured":"Vann Jones SA, O\u2019Brien JT. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med. 2014;44:673\u201383.","journal-title":"Psychol Med"},{"key":"3151_CR3","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1002\/mds.20535","volume":"20","author":"F Geser","year":"2005","unstructured":"Geser F, Wenning GK, Poewe W, McKeith I. How to diagnose dementia with Lewy bodies: State of the art. Mov Disord. 2005;20:S11-20.","journal-title":"Mov Disord"},{"key":"3151_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017;89:88\u2013100.","journal-title":"Neurology"},{"key":"3151_CR5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12883-022-02642-0","volume":"22","author":"E Khadhraoui","year":"2022","unstructured":"Khadhraoui E, M\u00fcller SJ, Hansen N, Riedel CH, Langer P, Tim\u00e4eus C, et al. Manual and automated analysis of atrophy patterns in dementia with Lewy bodies on MRI. BMC Neurol. 2022;22:114.","journal-title":"BMC Neurol"},{"key":"3151_CR6","doi-asserted-by":"publisher","first-page":"e8247","DOI":"10.1371\/journal.pone.0008247","volume":"4","author":"T Jubault","year":"2009","unstructured":"Jubault T, Brambati SM, Degroot C, Kullmann B, Strafella AP, Lafontaine AL, et al. Regional brain stem atrophy in idiopathic Parkinson\u2019s disease detected by anatomical MRI. PLoS One. 2009;4:e8247.","journal-title":"PLoS One"},{"key":"3151_CR7","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1212\/WNL.0b013e318292a2d2","volume":"80","author":"LA Massey","year":"2013","unstructured":"Massey LA, Jager HR, Paviour DC, O\u2019Sullivan SS, Ling H, Williams DR, et al. The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy. Neurology. 2013;80:1856\u201361.","journal-title":"Neurology"},{"key":"3151_CR8","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1212\/01.WNL.0000165960.04422.D0","volume":"64","author":"H Oba","year":"2005","unstructured":"Oba H, Yagishita A, Terada H, Barkovich AJ, Kutomi K, Yamauchi T, et al. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology. 2005;64:2050\u20135.","journal-title":"Neurology"},{"key":"3151_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1148\/radiol.2453061703","volume":"246","author":"A Quattrone","year":"2008","unstructured":"Quattrone A, Nicoletti G, Messina D, Fera F, Condino F, Pugliese P, et al. MR Imaging Index for Differentiation of Progressive Supranuclear Palsy from Parkinson Disease and the Parkinson Variant of Multiple System Atrophy. Radiology. 2008;246:214\u201321.","journal-title":"Radiology"},{"key":"3151_CR10","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/mds.23529","volume":"26","author":"M Morelli","year":"2011","unstructured":"Morelli M, Arabia G, Salsone M, Novellino F, Giofr\u00e8 L, Paletta R, et al. Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease: MR Imaging and Parkinson\u2019s Disease. Mov Disord. 2011;26:527\u201333.","journal-title":"Mov Disord"},{"key":"3151_CR11","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1212\/WNL.0b013e31822e55d0","volume":"77","author":"M Morelli","year":"2011","unstructured":"Morelli M, Arabia G, Novellino F, Salsone M, Giofre L, Condino F, et al. MRI measurements predict PSP in unclassifiable parkinsonisms: a cohort study. Neurology. 2011;77:1042\u20137.","journal-title":"Neurology"},{"key":"3151_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.parkreldis.2018.07.016","volume":"54","author":"A Quattrone","year":"2018","unstructured":"Quattrone A, Morelli M, Nigro S, Quattrone A, Vescio B, Arabia G, et al. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson\u2019s disease. Parkinsonism Relat Disord. 2018;54:3\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"3151_CR13","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, et al. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria: MDS Clinical Diagnostic Criteria for PSP. Mov Disord. 2017;32:853\u201364.","journal-title":"Mov Disord"},{"key":"3151_CR14","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc. 2015;30:1591\u2013601.","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"3151_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk J, Alavi A, Hurtig H, Zimmerman R. MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. Am J Roentgenol. 1987;149:351\u20136.","journal-title":"Am J Roentgenol"},{"key":"3151_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000117270","volume":"36","author":"F Pasquier","year":"1996","unstructured":"Pasquier F, Leys D, Weerts JGE, Mounier-Vehier F, Barkhof F, Scheltens P. Inter-and Intraobserver Reproducibility of Cerebral Atrophy Assessment on MRI Scans with Hemispheric Infarcts. Eur Neurol. 1996;36:268\u201372.","journal-title":"Eur Neurol"},{"key":"3151_CR17","doi-asserted-by":"publisher","first-page":"117012","DOI":"10.1016\/j.neuroimage.2020.117012","volume":"219","author":"L Henschel","year":"2020","unstructured":"Henschel L, Conjeti S, Estrada S, Diers K, Fischl B, Reuter M. FastSurfer - A fast and accurate deep learning based neuroimaging pipeline. Neuroimage. 2020;219:117012.","journal-title":"Neuroimage"},{"key":"3151_CR18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neuroimage.2015.02.065","volume":"113","author":"JE Iglesias","year":"2015","unstructured":"Iglesias JE, Van Leemput K, Bhatt P, Casillas C, Dutt S, Schuff N, et al. Bayesian segmentation of brainstem structures in MRI. Neuroimage. 2015;113:184\u201395.","journal-title":"Neuroimage"},{"key":"3151_CR19","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","volume":"62","author":"B Fischl","year":"2012","unstructured":"Fischl B. FreeSurfer NeuroImage. 2012;62:774\u201381.","journal-title":"FreeSurfer NeuroImage"},{"key":"3151_CR20","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1037\/0033-2909.86.2.420","volume":"86","author":"PE Shrout","year":"1979","unstructured":"Shrout PE, Fleiss JL. Intraclass correlations: Uses in assessing rater reliability. Psychol Bull. 1979;86:420\u20138.","journal-title":"Psychol Bull"},{"key":"3151_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016;15:155\u201363.","journal-title":"J Chiropr Med"},{"key":"3151_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2307\/3001913","volume":"5","author":"JW Tukey","year":"1949","unstructured":"Tukey JW. Comparing Individual Means in the Analysis of Variance. Biometrics. 1949;5:99.","journal-title":"Biometrics"},{"key":"3151_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/978-1-4419-9863-7_1213","volume-title":"Encyclopedia of Systems Biology","author":"W Haynes","year":"2013","unstructured":"Haynes W. Bonferroni Correction. In: Dubitzky W, Wolkenhauer O, Cho KH, Yokota H, editors. Encyclopedia of Systems Biology. New York, NY: Springer New York; 2013. p. 154\u2013154."},{"key":"3151_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology. 1967;17:427\u2013427.","journal-title":"Neurology"},{"key":"3151_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/bpa.12168","volume":"25","author":"K Seidel","year":"2015","unstructured":"Seidel K, Mahlke J, Siswanto S, Kr\u00fcger R, Heinsen H, Auburger G, et al. The Brainstem Pathologies of Parkinson\u2019s Disease and Dementia with Lewy Bodies: The Brainstem in iPD and DLB. Brain Pathol. 2015;25:121\u201335.","journal-title":"Brain Pathol"},{"key":"3151_CR26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/ene.13185","volume":"24","author":"Y Lee","year":"2017","unstructured":"Lee Y, Lee DK, Lee JM, Chung SJ, Lee JJ, Sohn YH, et al. Volumetric analysis of the cerebellum in patients with progressive supranuclear palsy. Eur J Neurol. 2017;24:212\u20138.","journal-title":"Eur J Neurol"},{"key":"3151_CR27","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/ene.13314","volume":"24","author":"M Silsby","year":"2017","unstructured":"Silsby M, Tweedie-Cullen RY, Murray CR, Halliday GM, Hodges JR, Burrell JR. The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias. Eur J Neurol. 2017;24:956\u201365.","journal-title":"Eur J Neurol"},{"key":"3151_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.parkreldis.2020.08.004","volume":"79","author":"H Sj\u00f6str\u00f6m","year":"2020","unstructured":"Sj\u00f6str\u00f6m H, Granberg T, Hashim F, Westman E, Svenningsson P. Automated brainstem volumetry can aid in the diagnostics of parkinsonian disorders. Parkinsonism Relat Disord. 2020;79:18\u201325.","journal-title":"Parkinsonism Relat Disord"},{"key":"3151_CR29","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/mds.28348","volume":"36","author":"L Chougar","year":"2021","unstructured":"Chougar L, Faouzi J, Pyatigorskaya N, Yahia-Cherif L, Gaurav R, Biondetti E, et al. Automated Categorization of Parkinsonian Syndromes Using Magnetic Resonance Imaging in a Clinical Setting. Mov Disord. 2021;36:460\u201370.","journal-title":"Mov Disord"},{"key":"3151_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00415-007-0656-y","volume":"255","author":"J Slowinski","year":"2008","unstructured":"Slowinski J, Imamura A, Uitti RJ, Pooley RA, Strongosky AJ, Dickson DW, et al. MR imaging of brainstem atrophy in progressive supranuclear palsy. J Neurol. 2008;255:37\u201344.","journal-title":"J Neurol"},{"key":"3151_CR31","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10072-017-2812-1","volume":"38","author":"BC Kim","year":"2017","unstructured":"Kim BC, Choi SM, Choi KH, Nam TS, Kim JT, Lee SH, et al. MRI measurements of brainstem structures in patients with vascular parkinsonism, progressive supranuclear palsy, and Parkinson\u2019s disease. Neurol Sci. 2017;38:627\u201333.","journal-title":"Neurol Sci"},{"key":"3151_CR32","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1212\/01.WNL.0000151854.85743.C7","volume":"64","author":"DC Paviour","year":"2005","unstructured":"Paviour DC, Price SL, Stevens JM, Lees AJ, Fox NC. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology. 2005;64:675\u20139.","journal-title":"Neurology"},{"key":"3151_CR33","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1007\/s00415-020-10327-2","volume":"268","author":"S Kannenberg","year":"2021","unstructured":"Kannenberg S, Caspers J, Dinkelbach L, Moldovan A-S, Ferrea S, S\u00fcdmeyer M, et al. Investigating the 1-year decline in midbrain-to-pons ratio in the differential diagnosis of PSP and IPD. J Neurol. 2021;268:1526\u201332.","journal-title":"J Neurol"},{"key":"3151_CR34","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/mds.20877","volume":"21","author":"DC Paviour","year":"2006","unstructured":"Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations: MRI-Based Clinico-Radiological Correlations. Mov Disord. 2006;21:989\u201396.","journal-title":"Mov Disord"},{"key":"3151_CR35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3233\/JAD-2010-100333","volume":"22","author":"B Borroni","year":"2010","unstructured":"Borroni B, Malinverno M, Gardoni F, Grassi M, Parnetti L, Agosti C, et al. A Combination of CSF Tau Ratio and Midsaggital Midbraintopons Atrophy for the Early Diagnosis of Progressive Supranuclear Palsy. J Alzheimers Dis. 2010;22:195\u2013203.","journal-title":"J Alzheimers Dis"},{"key":"3151_CR36","doi-asserted-by":"publisher","first-page":"815813","DOI":"10.3389\/fnagi.2022.815813","volume":"14","author":"N Hansen","year":"2022","unstructured":"Hansen N, M\u00fcller SJ, Khadhraoui E, Riedel CH, Langer P, Wiltfang J, et al. Metric magnetic resonance imaging analysis reveals pronounced substantia-innominata atrophy in dementia with Lewy bodies with a psychiatric onset. Front Aging Neurosci. 2022;14:815813.","journal-title":"Front Aging Neurosci"},{"key":"3151_CR37","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.neuroimage.2010.03.005","volume":"51","author":"S Baudrexel","year":"2010","unstructured":"Baudrexel S, N\u00fcrnberger L, R\u00fcb U, Seifried C, Klein JC, Deller T, et al. Quantitative mapping of T1 and T2* discloses nigral and brainstem pathology in early Parkinson\u2019s disease. Neuroimage. 2010;51:512\u201320.","journal-title":"Neuroimage"},{"key":"3151_CR38","doi-asserted-by":"publisher","first-page":"e0198250","DOI":"10.1371\/journal.pone.0198250","volume":"13","author":"S Eminian","year":"2018","unstructured":"Eminian S, Hajdu SD, Meuli RA, Maeder P, Hagmann P. Rapid high resolution T1 mapping as a marker of brain development: Normative ranges in key regions of interest. PLoS One. 2018;13:e0198250.","journal-title":"PLoS One"},{"key":"3151_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1874347101509010001","volume":"9","author":"X Wang","year":"2015","unstructured":"Wang X, Roeloffs V, Merboldt KD, Voit D, Sch\u00e4tz S, Frahm J. Single-shot Multi-slice T1 Mapping at High Spatial Resolution \u2013 Inversion-Recovery FLASH with Radial Undersampling and Iterative Reconstruction. Open Med Imaging J. 2015;9:1\u20138.","journal-title":"Open Med Imaging J"},{"key":"3151_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.mri.2016.10.022","volume":"36","author":"K Jiang","year":"2017","unstructured":"Jiang K, Zhu Y, Jia S, Wu Y, Liu X, Chung YC. Fast T1 mapping of the brain at high field using Look-Locker and fast imaging. Magn Reson Imaging. 2017;36:49\u201355.","journal-title":"Magn Reson Imaging"},{"key":"3151_CR41","doi-asserted-by":"publisher","first-page":"e038120","DOI":"10.1136\/bmjopen-2020-038120","volume":"10","author":"CR McCreary","year":"2020","unstructured":"McCreary CR, Salluzzi M, Andersen LB, Gobbi D, Lauzon L, Saad F, et al. Calgary Normative Study: design of a prospective longitudinal study to characterise potential quantitative MR biomarkers of neurodegeneration over the adult lifespan. BMJ Open. 2020;10:e038120.","journal-title":"BMJ Open"},{"key":"3151_CR42","doi-asserted-by":"publisher","unstructured":"M\u00fcller SJ, Khadhraoui E, Voit D, Riedel CH, Frahm J, Ernst M. First clinical application of a novel T1 mapping of the whole brain. Neuroradiol J. 2022. https:\/\/doi.org\/10.1177\/197140092210842.","DOI":"10.1177\/197140092210842"},{"key":"3151_CR43","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/mds.28007","volume":"35","author":"S Nigro","year":"2020","unstructured":"Nigro S, Antonini A, Vaillancourt DE, Seppi K, Ceravolo R, Strafella AP, et al. Automated MRI Classification in Progressive Supranuclear Palsy: a Large International Cohort Study. Mov Disord. 2020;35:976\u201383.","journal-title":"Mov Disord"},{"key":"3151_CR44","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1093\/brain\/awl021","volume":"129","author":"DC Paviour","year":"2006","unstructured":"Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain. 2006;129:1040\u20139.","journal-title":"Brain"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03151-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-023-03151-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03151-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T12:06:13Z","timestamp":1679400373000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-023-03151-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3151"],"URL":"https:\/\/doi.org\/10.1186\/s12883-023-03151-4","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,21]]},"assertion":[{"value":"21 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was ethically approved by the institutional review board of the University Medical Center G\u00f6ttingen (No. 16\/04\/2022, \u201cEthics Committee of the University of G\u00f6ttingen\u201d, Von-Siebold-Str. 4, 37075 G\u00f6ttingen, Germany) and adhered to the 2013 Helsinki Declaration.Due to the retrospective, observational nature of the study, the ethics committee (\u201cEthics Committee of the University of G\u00f6ttingen\u201d) waived the need for informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. JW is an advisory board member of Abbott, Biogen, Boehringer Ingelheim, Immunogenetics, Lilly, MSD Sharp & Dohme, and Roche Pharma. JW received honoraria for lectures from the AGNP, Actelion, Amgen, Beeijing Yibai Science and Technology Ltd., CSF-Society, Helios Klinikum Wuppertal, Janssen Cilag, Med Update GmbH, Pfizer, Roche Pharma, and Vitos Kurhessen-Bad Emstal. JW holds the following patents: PCT\/EP 2011 001724 and PCT\/EP 2015 052945, MB has received funding from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) \u2013 413501650. FM received speaker honoraria from BIAL and Abbvie. CvR speaker honoraria\/counseling for Abbvie and Zambon.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}